Fever-Tree Cancels Shares After Latest London Buyback Tranche

An update from Fevertree Drinks ( (GB:FEVR) ) is now available.

Fevertree Drinks has repurchased a series of its own ordinary shares between 23 and 27 March 2026 under an authority granted at its 2025 annual meeting, executing the trades through its broker Investec Bank. The company plans to cancel the repurchased shares, which will reduce the number of shares in issue and is likely to enhance earnings per share and consolidate existing shareholders’ stakes.

The buyback was conducted on the London Stock Exchange at volume-weighted average prices ranging roughly between 748p and 801p, with daily volumes just under 16,000 shares. This latest tranche forms part of Fever-Tree’s broader share buyback programme, underlining management’s capital allocation strategy and signalling confidence in the company’s prospects to the market.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £817.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Spark’s Take on FEVR Stock

According to Spark, TipRanks’ AI Analyst, FEVR is a Neutral.

Overall score is driven by a strong, low-leverage balance sheet but offset by weaker recent operating trends and volatile cash generation. Technicals are notably weak (below major moving averages with negative MACD), and valuation is stretched given the high P/E despite a moderate dividend yield.

To see Spark’s full report on FEVR stock, click here.

More about Fevertree Drinks

Fevertree Drinks plc, known as Fever-Tree, operates in the beverages industry and specialises in premium carbonated mixers such as tonic waters and related drinks. The company is listed in London and targets both on-trade and retail markets, positioning itself as a high-end partner to spirits brands and consumers seeking premium drink experiences.

Average Trading Volume: 302,802

Technical Sentiment Signal: Strong Sell

Current Market Cap: £896.5M

See more insights into FEVR stock on TipRanks’ Stock Analysis page.